Dr Andrew Harvey heads the Queensland Emory Drug Discovery Initiative (QEDDI), a UQ-owned, dedicated small molecule drug discovery and development group.

QEDDI’s goal is to leverage UQ research and accelerate the development of new drugs that offer tangible clinical benefit.

It comprises core capabilities in industry-based project management, medicinal chemistry and in vitro pharmacology.

QEDDI brings together UQ research experts with drug discovery scientists recruited from industry through collaboration in focused project teams.

QEDDI was established in 2015 by and as a business unit of UQ’s main commercialisation company, UniQuest in collaboration with Emory University and is supported by the Queensland Government through the Advance Queensland Initiative.

Projects will be selected for QEDDI support based on commercial potential, unmet clinical need and input from an independent industry advisory committee.

More information about QEDDI at www.qeddi.com.au

Publications by Andrew Harvey